Insider Trading & Ownership - Newton Charles W.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Newton Charles W.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-05-13
Sale
2025-05-15
4:33 pm
2seventy bio Inc.TSVTNewton Charles W.
Director
17,092$0$00
(Direct)
View
2025-03-17
Purchase
2025-03-18
7:01 pm
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
200,000$0.5581$111,620372,725
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-06-12
Option Award
2025-06-13
6:47 pm
N/A
2035-06-12
Coherus Oncology Inc.CHRSNewton Charles W.
Director
112,000$0112,000
(Direct)
View
2025-05-13
Equity Swap
2025-05-15
4:33 pm
N/A
N/A
2seventy bio Inc.TSVTNewton Charles W.
Director
5,533$00
(Direct)
View
2025-04-25
Option Award
2025-04-29
08:08 am
2026-04-25
2035-04-25
NOVAVAX INCNVAXNewton Charles W.
Director
71,400$071,400
(Direct)
View
2025-02-10
Option Award
2025-02-26
7:29 pm
N/A
2035-02-09
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
618,750$0678,975
(Direct)
View
2024-06-10
Option Award
2024-06-12
6:52 pm
N/A
2034-06-10
2seventy bio Inc.TSVTNewton Charles W.
Director
18,075$034,675
(Direct)
View
2024-06-03
Option Award
2024-06-05
6:52 pm
N/A
2034-06-03
Coherus BioSciences Inc.CHRSNewton Charles W.
Director
112,000$0112,000
(Direct)
View
2024-03-20
Option Award
2024-03-25
4:28 pm
N/A
2034-03-20
2seventy bio Inc.TSVTNewton Charles W.
Director
50,000$050,000
(Direct)
View
2024-02-09
Option Award
2024-02-13
8:19 pm
N/A
2034-02-08
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
440,000$0448,729
(Direct)
View
2023-11-16
Option Award
2023-11-20
8:55 pm
N/A
2031-02-04
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
4,818,000$04,826,729
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:56 pm
N/A
2033-06-07
Coherus BioSciences Inc.CHRSNewton Charles W.
Director
38,250$038,250
(Direct)
View
2023-02-24
Option Award
2023-02-28
6:13 pm
N/A
2033-02-23
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
700,000$0702,941
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:50 pm
N/A
2032-05-04
Coherus BioSciences Inc.CHRSNewton Charles W.
Director
54,000$054,000
(Direct)
View
2022-03-16
Option Award
2022-03-18
4:09 pm
N/A
2032-03-15
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
500,000$0500,000
(Direct)
View

Ownership
2021-06-16
7:21 pm
N/A
2031-02-04
Lyell Immunopharma Inc.LYELNewton Charles W.
Chief Financial Officer
0$04,318,000
(Direct)
View